Lilian Stern

Principal

Founder and principal, providing differentiated investor and communications consulting to more than 500 biotechnology companies, spanning specialty pharmacy, innovative diagnostics, and vaccine development. Attracted premier institutional investors as stakeholders in client companies. Supported talented investment bankers, analysts, and equity capital markets professionals.

Passionate about

Contributing to human health by facilitating capital into the industry.

How can Precision AQ help you?

Navigate the New Era of Healthcare with Precision AQ.